Cumberland Partners’s CME Group CME Stock Holding History

Cumberland Partners’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-8,200	Closed	-$2.22M	–	175
2025 Q3	$2.22M	Buy	8,200 +7,200	+720%	+$1.96M	0.14%	99
2025 Q2	$276K	Sell	1,000 -1,000	-50%	-$272K	0.02%	163
2025 Q1	$531K	Sell	2,000 -6,000	-75%	-$1.48M	0.04%	149
2024 Q4	$1.86M	Buy	+8,000	New	+$1.84M	0.13%	107
2024 Q2	–	Sell	-8,000	Closed	-$1.72M	–	179
2024 Q1	$1.72M	Buy	+8,000	New	+$1.68M	0.13%	97

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cumberland Partners's CME Position: Q4 2025 in Review

Cumberland Partners sold out of CME Group (CME) in Q4 2025, closing a stake of 8,200 shares — an estimated $2.22M sold.

Cumberland Partners first reported a position in CME in Q1 2024 and held it in 5 quarters. The position peaked at $2.22M in Q3 2025. 1,731 funds tracked by Wall St. Rank hold CME as of Q4 2025.

Cumberland Partners reported no remaining CME Group position as of Q4 2025 after selling out during the quarter.
Cumberland Partners sold 8,200 CME Group shares in Q4 2025, an estimated $2.22M.
Cumberland Partners first reported a position in CME Group in Q1 2024 and held it in 5 quarters.
Cumberland Partners's CME Group position peaked at $2.22M in Q3 2025.
1,731 funds tracked by Wall St. Rank held CME Group as of Q4 2025.

Based on Cumberland Partners's 13F filing for Q4 2025, filed 6 Feb 2026.